Skærmbilleder

Beskrivelse

Learn about RECIST 1.1 and how it can be applied to your clinical trial.

RECIST (Response Evaluation Criteria In Solid Tumors) is a set of published rules that define when cancer patients improve ("respond"), stay the same ("stable") or worsen ("progression") during treatments.

Nyheder

Version 2.0.1

Improved RECIST calculations which includes percent changes from Nadir.
User can enter Baseline and up to 9 follow up time points.
Target lesion measurements can be designated as lymph nodes.

Oplysninger

Sælger
PAREXEL International Corporation
Størrelse
8 MB
Kategori
Medicinsk
Kompatibilitet
Kræver iOS 8.0 eller nyere. Kompatibel med iPhone 5s, iPhone 6, iPhone 6 Plus, iPhone 6s, iPhone 6s Plus, iPhone SE, iPhone 7, iPhone 7 Plus, iPhone 8, iPhone 8 Plus, iPhone X, iPad Air, iPad Air Wi‑Fi + Cellular, iPad mini 2, iPad mini 2 Wi-Fi + Cellular, iPad Air 2, iPad Air 2 Wi-Fi + Cellular, iPad mini 3, iPad mini 3 Wi-Fi + Cellular, iPad mini 4, iPad mini 4 Wi-Fi + Cellular, 12,9" iPad Pro, 12,9" iPad Pro Wi-Fi + Cellular, 9,7" iPad Pro, 9,7" iPad Pro Wi-Fi + Cellular, iPad (5. generation), iPad Wi-Fi + Cellular (5. generation), 12,9" iPad Pro (2. generation), 12,9" iPad Pro Wi‑Fi + Cellular (2. generation), 10,5" iPad Pro, 10,5" iPad Pro Wi‑Fi + Cellular og iPod touch (6. generation).
Sprog
Engelsk
Alder
Vurderet 12+ pga. følgende:
Sporadisk/mild information om medicin/behandling
Copyright
© PAREXEL Informatics
Pris
Gratis

Understøtter

  • Familiedeling

    Op til seks familiemedlemmer vil kunne bruge denne app, når Familiedeling aktiveres.

Mere fra denne udvikler